Association between Helicobacter pylori, Epstein-Barr virus, human papillomavirus and gastric adenocarcinomas

doi:10.3748/wjg.v24.i43.4928

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 43

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9190)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.

Item

Count

PDF

648

WORD

312

HTML

5132

Tables (1-2)

251

Sum=6343

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1206

Download

1641

Sum=2847

Nov 21, 2018 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (43)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Nov 21, 2018; 24(43): 4928-4938
Published online Nov 21, 2018. doi: 10.3748/wjg.v24.i43.4928

Table 2 Ratio, in absolute value and percentage, between pathogen (Helicobacter pylori, Epstein-Barr virus, and human papillomavirus), strain (HPcagA) and tumor location

Infection	Cardia (104)	P (OR, 95%CI)	Fundus (57)	P (OR, 95%CI)	Body (45)	P (OR, 95%CI)	Antrum (95)	P (OR, 95%CI)
HP+ (263)	91 (34.6%)	0.975 (OR = 1.012, 95%CI: 0.494-2.071)	44 (16.7%)	0.012 (OR = 0.395, 95%CI: 0.188-0.831)	40 (15.2%)	0.704 (OR = 1.213, 95%CI: 0.447-3.291)	88 (33.5%)	0.064 (OR = 2.214, 95%CI: 0.938-5.228)
H. pylori-cagA+ (203)	67 (33%)	0.400 (OR = 0.806, 95%CI: 0.488-1.332)	27 (13.3%)	0.000 (OR = 0.361, 95%CI: 0.201-0.648)	35 (17.2%)	0.092 (OR = 1.886, 95%CI: 0.894-3.978)	74 (36.5%)	0.009 (OR = 2.087, 95%CI: 1.191-3.656)
EBV+ (62)	23 (37.1%)	0.621 (OR = 1.158, 95%CI: 0.648-2.069)	1 (1.6%)	0.000 (OR = 0.053, 95%CI: 0.007-0.388)	16 (25.8%)	0.009 (OR = 2.435, 95%CI: 1.227-4.833)	22 (35.5%)	0.444 (OR = 1.258, 95%CI: 0.699-2.266)
HPV+ (8)	4 (50%)	0.348 (OR = 1.940, 95%CI: 0.475-7.920)	0 (0%)	0.162 (OR = 0.803, 95%CI: 0.758-0.850)	2 (25%)	0.436 (OR = 1.894, 95%CI: 0.370-9.686)	2 (25%)	0.690 (OR = 0.720, 95%CI: 0.143-3.637)

EBV: Epstein-Barr virus; HPV: Human papillomavirus; H. pylori: Helicobacter pylori.

Citation: de Souza CRT, Almeida MCA, Khayat AS, da Silva EL, Soares PC, Chaves LC, Burbano RMR. Association between Helicobacter pylori, Epstein-Barr virus, human papillomavirus and gastric adenocarcinomas. World J Gastroenterol 2018; 24(43): 4928-4938
URL: https://www.wjgnet.com/1007-9327/full/v24/i43/4928.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i43.4928